baber/WOPTO huggingface dataset:
Patent NZ-332924-A (NZ)
Title: Blowing head with buckle detector for optical fibre installation in ducts
Inventor: BARKER PHILIP ALFRED
IPC: H02G1/08
Filed: 1997-09-17
Abstract: A blowing head is disclosed for a blown optical fibre installation, the blowing head including means for detecting buckling in the transmission line being installed and decreasing the drive forces applied to the transmission line, preventing mechanical damage occurring to the transmission line.
Patent NZ-333382-A (NZ)
Title: N-[4-(heteroarylmethyl)phenyl]-heteroarylamines
Inventor: VENET MARC GASTON
IPC: A61K31/47
Filed: 1997-06-19
Abstract: The specification describes compounds of above formula (I), the N-oxides, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein R1 is hydrogen, hydroxy, C1-6alkyl or aryl; R2 is hydrogen; optionally substituted C1-12alkyl; C3-7cycloalkyl; C2-8alkenyl, optionally substituted pyrrolidinyl or aryl; R3 is hydrogen, optionally substituted C1-6alkyl or aryl; Het is an optionally substituted unsaturated heterocycle selected from imidazolyl, triazolyl, tetrazolyl and pyridinyl. Intermediates are also disclosed
Patent NZ-333968-A (NZ)
Title: Game board with triangular divisions and playing pieces comprising triangles or blocks, four and eight sided, to be stacked
Inventor: DUFFIELD MICHAEL JOHN
IPC: A63F9/34
Filed: 1999-02-01
Abstract: The game consists firstly of a board that is divided into a plurality of triangular sections (5). The board could be made of paper, plastic, wood or metal, but preferably is steel or other magnetisable material. This will allow attraction of the playing pieces (36) to the board for resiliency and ease of playing. The playing pieces, such as a tetrahedron and octahedron, (36) have at least 2 triangular sides each. The playing piece (36), having multiple triangular surfaces (36,32) allows for the rotation of the playing piece onto other triangular sections across the playing surface (5). The aim of the game is to move a set of playing pieces from one starting area to an arrival area before other players complete this task. For this, the starting position might be a stacked pyramid formed by the plurality of playing pieces.
Patent NZ-335870-A (NZ)
Title: Process for the preparation of NMDA antagonists
Inventor: HARRIS ALAN RICHARD
IPC: C07C269/06
Filed: 1997-12-12
Abstract: A process for the production of a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein: R1 and R2 are independently phenyl or 4-fluorophenyl; R3 is hydrogen, alkyl or methoxycarbonyl; R4 is hydrogen or methyl; which comprises reaction of a compound of formula (II) with a compound of formula (III), wherein R5-R10 are independently alkyl to give a compound of formula (IV), followed by deprotection and optionally thereafter forming a pharmaceutically acceptable salt.
Patent NZ-337068-A (NZ)
Title: Yoke formed integrally with stator slot teeth in rotating electrical machine
Inventor: LEIJON MATS
IPC: H02K3/48
Filed: 1998-02-02
Abstract: A device is disclosed for increasing the mechanical rigidity and natural frequency of the stator in a rotating electric machine, which stator is provided with stator teeth between the slots (2) holding the winding (12), stator teeth (4, 6), the free ends of which are situated at the air gap between stator and rotor, have at least one yoke (14) formed in one piece with adjacent stator teeth, arranged across each stator slot in order to mechanically secure the stator teeth in tangential direction.
Patent NZ-503683-A (NZ)
Title: Processes and intermediates for preparing anti-cancer quinazoline compounds
Inventor: LEHNER RICHARD SHELTON
IPC: A61K31/505
Filed: 2000-03-30
Abstract: A method of preparing a compound of formula 1 comprising: (a) treating a compound of formula 5 with thionyl chloride in anhydrous dichloromethane to forma compound of formula 3; (b) reacting a compound of formula 3 with a compound of formula 4 to form a compound of formula 2; and (c) treating a compound of formula 2 with either an alkali-metal or alkaline-metal hydroxide in a solvent comprising hydroxy-substituted alkyl or a tetra-alkylammonium fluoride compound in an aprotic solvent. A method for preparing a compound of formulae 6 or 7 comprising: (a) treating a compound of formula 8 with a primary or secondary alcohol of the formula R7-OH in the presence of an alkali-metal or alkaline-metal hydroxide to form a compound of formula 7; or (b) treating a compound of formula 8 with a secondary alcohol of the formula R7-OH in the presence of an alkali-metal or alkaline-metal hydroxide to form a compound of formula 6. In formulae 1-8: R1 and R2 are each independently selected from alkyl and alkoxy which are optionally substituted by up to two substituents independently selected from hydroxy and alkoxy; R15 is hydrogen, alkyl or -(CH2)q-aryl wherein q is an integer from 0-4; G is blocking group -C(OH)R3R4 or -SiR3R4R5; G is blocking group -C(OH)R3R4; R3, R4 and R5 are each independently alkyl; R6 is alkyl or -(CH2)mO(CH2)nCH3; each m is independently an integer from 1-6 and each n is an integer from 0-3; and R7 is -alkyl or -alkylaryl optionally substituted with 1-3 substituents independently selected from halo, nitro, trifluoromethoxy, sulfonyl, alkyl, alkoxy, aryloxy and arylsulfonyl.
Patent NZ-504527-A (NZ)
Title: Electrochemical biosensor test strip
Inventor: SURRIDGE NIGEL A
IPC: G01N33/48
Filed: 1998-12-02
Abstract: An electrochemical biosensor test strip with four new features. The test strip includes an indentation for tactile feel as to the location of the strips sample application port. The sample application port leads to a capillary test chamber, which includes a test reagent. The wet reagent includes from about 0.2% by weight to about 2% by weight polyethylene oxide from about 100 kilodaltons to about 900 kilodaltons mean molecular weight, which makes the dried reagent more hydrophilic and sturdier to strip processing steps, such as mechanical punching, and to mechanical manipulation by the test strip user. The roof of the capillary test chamber includes a transparent or translucent window which operates as a "fill to here" line, thereby identifying when enough test sample (a liquid sample, such as blood) has been added to the test chamber to accurately perform a test. The test strip may further include a notch located at the sample application port. The notch reduces a phenomenon called "dose hesitation".
Patent NZ-506054-A (NZ)
Title: Biocidal compositions in the form of a suspoemulsion comprising water insoluble biocides A and B and a mixture of surfactants
Inventor: PFAMMATTER FREDDY
IPC: A01P21/00
Filed: 1999-02-08
Abstract: Described are pesticidal compositions in form of aqueous suspoemulsions.  The compositions comprise at least two pesticides which are substantially insoluble in water, wherein one pesticide A is solid and the other pesticide B is liquid or is dissolved in a hydrophobic organic solvent, and a combination of surfactants comprising (1) a tristyrylphenol-ethoxylate having 6-14 mol ethoxylate, in non-ionic form, and (2) a tristyrylphenol-ethoxylate having 14-18 mol ethoxylate in form of its sulphate or phosphate, in anionic or acid form, and (3) a dialkyl-sulfosuccinate salt.
Patent NZ-507202-A (NZ)
Title: Process for preparing beta keto esters and 1,3-dione compounds
Inventor: CRAMP SUSAN MARY
IPC: C07C315/04
Filed: 1999-03-22
Abstract: A process for the preparation of a compound of formula (I), wherein one of the groups R1 and R2 is cyclopropyl and the other is phenyl substituted by two or three groups, which may be the same or different selected from halogen, nitro, cyano, - (CR4R5) S (O) pR6, -S (O) pR6, C1-6 alkoxy, C1-4 haloalkoxy, C1-4 alkyl, C1-4 haloalkyl, 1,2,4- triazol-l-yl and -SF5; wherein:  p is zero, one or two; R4 and R5 are independently hydrogen or C1-4 alkyl; and R6 is C1-4 alkyl; which process comprises the hydrolysis and decarboxylation of a compound of formula (II).  In the presence of water wherein R1 and R2 are as hereinbefore defined, and R3 is C1-4 alkyl.
Patent NZ-508634-A (NZ)
Title: Wound dressing in the treatment of acute (burn) wounds where the dressing adheres to the wound to provide epithelial outgrowth conditions
Inventor: KREIS ROBERT WALTER
IPC: A61L15/28
Filed: 1999-06-07
Abstract: Disclosed is a use of highly absorbent fibres in the manufacture of a wound dressing which becomes adherent to the wound for use in the treatment of burns. Using such a dressing, the wound is provided with conditions that are conducive to epithelial outgrowth. Examples of the fibres are alginate, viscose, modified cellulose, polyester and polypropylene.
Patent NZ-510364-A (NZ)
Title: Biofouling control with an oil-in-water emulsion comprising an antimicrobial oil phase and an emulsifier targeting biofilms, cell surfaces and cell aggregates
Inventor: YANG SHUNONG
IPC: A01N25/30
Filed: 1999-06-25
Abstract: Described is a method for controlling biofouling in an aqueous medium by treating the aqueous medium with an oil-in-water emulsion comprising an antimicrobial oil phase and at least one emulsifier.  This method efficiently controls biofouling in the aqueous medium by specifically targeting the antimicrobial oil phase directly to biofilms, cell surfaces and cell aggregates in a concentrated form.
Patent NZ-511215-A (NZ)
Title: Matrix or membrane comprising a siloxane-based elastomer through which a drug can permeate at a controlled rate
Inventor: MARKKULA TOMMI
IPC: A61K9/58
Filed: 1999-10-26
Abstract: Described is a siloxane-based elastomer intended for controlling the permeation of drugs, wherein the elastomer includes 3,3,3,-trifluoropropyl groups attached to the Si-atoms of the siloxane units.  Also described is a method for the preparation of a siloxane-based elastomer including 3,3,3,-trifluoropropyl substituents, where the elastomer is intended for controlling the permeation of drugs.  In the method, either: i) a 3,3,3,-trifluoropropyl-substituted vinyl-functional polysiloxane component and a silicon hydride-functional crosslinking agent are crosslinked in the presence of a catalyst; or, ii) a 3,3,3,-trifluoropropyl-substituted polysiloxane component is crosslinked in the presence of a peroxide catalyst.
Patent NZ-513580-A (NZ)
Title: Energy monitoring and charging system
Inventor: HOLTOM STEPHEN WAYNE
IPC: H01T13/60
Filed: 1999-06-09
Abstract: A  battery management system (40) for a  battery  (80) having   a plurality  of  cells  (81  to  86)  includes   a microprocessor for controlling the operation of the  battery management  system, according  to  preset  individual  cell testing  and charging functions. There is also an individual cell monitor having a separate conductor to the junction  of each cell to measure the cell voltage. The measurements  are then  converted  into digital signals to  be fed  into  the microprocessor. Then, according to the present functions,  a charge is effected to an appropriate cell.
Patent NZ-519822-A (NZ)
Title: Mixing apparatus and method
Inventor: AFNAN ALI MOHAMMAD
IPC: B01F29/60
Filed: 2001-02-12
Abstract: Mixing of components, e.g. pharmaceutical actives and excipients, is carried out while monitoring the spectroscopic profile of the mixture during the mixing process so that the spectroscopic profile may be used to determine the point at which mixing is terminated. In one embodiment of the invention, the spectroscopic data is collected by means of a monitoring unit mounted on the mixing vessel. the mixing vessel being mounted and driven so as to rotate or oscillate mounted and thereby effect mixing of its contents and the monitoring unit being mounted for rotation or oscillation with the vessel. When the spectroscopic data indicates that mixing has progressed to a desired state, e.g. the production of a homogeneous blend, the monitoring unit transmits a signal to the drive source to terminate rotation or oscillation of the vessel.
Patent NZ-521367-A (NZ)
Title: Material processing by repeated solvent expansion-contraction
Inventor: SAIM SAID
IPC: B01J19/00
Filed: 2001-01-30
Abstract: A method for repeatedly converting a solvent from a state of solvent to a state of antisolvent with relatively little loss of solvent. The method is used to allow for processing of large amounts of solute material with minimum amounts of solvent.
Patent NZ-522600-A (NZ)
Title: Regulating lipid levels via the Zmax1 or HBM gene
Inventor: CARULLI JOHN P
IPC: A61K48/00
Filed: 2001-05-25
Abstract: A method of identifying a molecule involved in lipid regulation comprises screening compounds or composition which bind to HBM or Zmax 1 nucleic acid or protein and then identifying whether the binding modulates lipid regulation. A nucleic acid comprising SEQ ID NO:2 or a protein comprising SEQ ID NO:4 can be used in the manufacture of a composition fro treating or preventing a lipid related disorder. Diagnostic methods for screening genetic predisposition to arteriosclerosis or a lipid-mediated disorder, methods of expressing an HBM protein in a tissue and the use of an agent which binds the extracellular domain of HBM or Zmax1 and thus regulates its activity in the manufacture of a medicament for modulating lipid levels are also described.
Patent NZ-522887-A (NZ)
Title: Query response system
Inventor: VAN DER ZANDEN ROGER JOSEPH
IPC: G06F17/30
Filed: 2002-11-28
Abstract: A method of providing a response to a query includes: (i) receiving query information and identity information from the user; (ii) searching for information identified by the query information and retrieving the information; (iii) delivering the retrieved information to the user; (iv) determining whether the delivered information can successfully be employed by the user to answer their query, and (v) contacting a specialist advisor if the user is unlikely to successfully employ the information delivered to answer their query.
Patent NZ-523384-A (NZ)
Title: Enzymes and polynucleotides encoding the same
Inventor: GREEN SOL
IPC: C07H21/04
Filed: 2002-12-24
Abstract: A polynucleotide encodes a multifunctional germacrene-D synthase having the amino sequence of SEQ ID NO:2. The polynucleotide is capable of facilitating the conversion of farnesyl diphosphate (FDP) to a mixture of germacrene-D and one or more other sesquiterpenes selected from delta-cadinene, delta-elemene, elemol, gamma-muurolene, gamma-cadinene, gamma-elemene and germacrene-B. Also described are vectors, host cells, and transgenic plants comprising the polynucleotide.
Patent NZ-525305-A (NZ)
Title: Method of and system for controlling the ratio of a variable lead parameter and an adjustable lag parameter for a lag-lead process
Inventor: BURNHAM KEITH J
IPC: F23N1/02
Filed: 2001-10-15
Abstract: A powdered medicine multi-dose administering device has a medicine container unit (5b) for containing a unit-dose of medicine under the lower surface of the medicine storage chamber (5a) storing the medicine in a multi-dose amount. A medicine guiding unit (2) moves between a filling position and an administering position while maintaining a contact with the bottom surface. At the filling position, the medicine container unit is opened to the medicine storage chamber and is filled with the medicine. As the medicine container unit moves from the filling position to the administering position, the powdered medicine in the medicine container unit is swept and metered. At the administering position, the medicine in the medicine container unit is injected by the action of the pump unit (3) through a filter (6) and a pipe (2g, 2d, 2c).
Patent NZ-525390-A (NZ)
Title: Compositions comprising lysine, proline, niacin and ascorbic acid and methods for lowering plasma lipoprotein(A) and risk factors of cardiovascular diseases
Inventor: RATH MATTHIAS
IPC: A61K31/198
Filed: 2001-10-03
Abstract: A composition comprises the ascorbic acid, ascorbyl palmitate, beta-, gamma-, delta-tocopherol-mix, beta-carotene, biotin, calcium ascorbate, calcium glycinate, caroteinoid mix:, cholecalciferol, chromium glycinate, citrus bioflavonoids, coenzyme Q10, copper glycinate, cyanocobalamin, d-alpha-tocopherol, di-calcium pantothenate, dicalcium phosphate, folic acid, inositol, L-arginine, L-camitine, L-cysteine, L-lysine, L-proline, L-selenomethionine, magnesium ascorbate, magnesium glycinate, manganese chelate, molybdenum glycinate, niacin, niacinamide, potassium chelate, pycnogenol, pyridoxine, riboflavin, thiamine, and zine glycinate, in therapeutically effective amounts to lower plasma concentration of a lipoprotein in a mammal.
Patent NZ-527989-A (NZ)
Title: Use of a halogenated 2-phenyl-1,2-ethanediol dicarbamate enantiomer or enantiomeric mixture wherein one enantiomer predominates for preventing or treating bipolar disorder
Inventor: PLATA-SALAMAN CARLOS R
IPC: A61K31/27
Filed: 2002-02-21
Abstract: Described is the use of a medicament for preventing or treating bipolar disorder comprising administering to a subject in need thereof a therapeutically effective amount of an enantiomer of formula (I) or enantiomeric mixture wherein one enantiomer of formula (I) predominates wherein phenyl is substituted at X with one to five halogen atoms selected from the group consisting of fluorine, chlorine, bromine and iodine; and, R1, R2, R3 and R4 are independently selected from the group consisting of hydrogen and C1-C4 alkyl; wherein C1-C4 alkyl is optionally substituted with phenyl (wherein phenyl is optionally substituted with substituents independently selected from the group consisting of halogen, C1-C4 alkyl, C1-C4 alkoxy, amino, nitro and cyano).
Patent NZ-532829-A (NZ)
Title: Film coated solid pharmaceutical compositions comprising sumatriptin for treating pain
Inventor: BAKER ROBERT WILLIAM
IPC: A61K31/00
Filed: 2002-12-04
Abstract: A film coated solid-dosage form pharmaceutical composition for oral administration comprising the 5HT1 receptor agonist, sumatriptan, which upon administration disintegrates and disperses within the gastrointestinal tract is described. The composition comprises sumatriptan in the amount of 20mg to 150mg, about 5 to 50% by weight of a base component of an effervescent couple, about 0.5 to about 10% by weight of a disintegrant and about 35 to 80% by weight of an insoluble filler. The insoluble filler includes a wicking agent. The composition is useful for in the treatment of conditions associated with cephalic pain such as cluster headaches, chronic paroxysmal, hemicrania, headache associated with vascular disorders, headache associated with substances or their withdrawal, rebound headache, tension headache and migraine.
Patent NZ-533793-A (NZ)
Title: Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, the preparation thereof and the application of same in therapeutics
Inventor: GALLI FREDERIC
IPC: A61P25/14
Filed: 2003-01-03
Abstract: Disclosed is a compound in the form of a pure enantiomer or in the form of a mixture of enantiomers complying with the general formula (I) in which: R represents a halogen atom, a cycloalkyl group or a substituted phenyl group; and one of the dashed lines is a double bond and the other is a single bond.
Patent NZ-534789-A (NZ)
Title: Animal ear tag with male portion having harder partial shell on softer core
Inventor: GARDNER MICHAEL STUART
Filed: 2004-08-17
Abstract: The male portion 1 of an animal tag has a stem 3 and a base portion 4 extending to core portion 4A which is of a softer material than the partial shell of harder material defining an outer surface of a tip 7 of head 5. When the head 5 engages with an opening 10 of a female tag 11 of rigid material, the partial shell 6 of hard material is able to compress around the softer material core 4A in a direction indicated by arrows Y and around the vertical axis X - X. In doing so the head 5 does not lose its essentially circular cross section so that entry through the circular opening 10 of the female tag 11 is not hindered.
Patent NZ-537787-A (NZ)
Title: Methods and systems for providing automated actions on recognized text strings in a computer-generated document
Inventor: REYNAR JEFFREY C
IPC: G06F17/21
Filed: 2005-01-19
Abstract: Methods provide for automatically performing actions on or in association with text or data strings that are recognized as belonging to certain semantic categories. Text entered by a user is passed to a recognizer application. If a given text or data string is recognized as belonging to a given semantic category, the recognizer application passes data corresponding to the recognized string back to a host application. In response to recognized text or data, a pointer to the object model of the host application may be passed to the recognizer application to allow the recognizer application to automatically perform one or more automated functions of the host application in response to the recognized string. Alternatively, after the recognizer application passes data corresponding to the recognized string back to the host application, the host application may fire an application level or document level event for causing an action component to automatically perform desired actions on recognized strings. Alternatively, after a string is recognized by the recognizer application, the recognizer application may set a property associated with a desired action to be automatically performed on or in association with the recognized string. The host application may call an action component identified by the property for automatically performing the desired action on or in association with the recognized string
Patent NZ-539470-A (NZ)
Title: Implantable medical devices incorporating deuterated rapamycin for controlled delivery thereof
Inventor: YATSCOFF RANDALL W
IPC: C07D498/18
Filed: 2003-11-17
Abstract: An implantable medical device having a structure adapted for introduction into a patient is disclosed, wherein the structure is incorporated with a therapeutic agent comprising a deuterated rapamycin. Deuterated rapaymcin can be controllably introduced at target locations within the patient's body by using an implantable medical device having a structure incorporated with a therapeutic agent comprising a deuterated rapamycin. Representative deuterated rapamycins include epi-7-deuteromthyl rapamycin, 7,43-d6 rapamycin, 7-deuteromethyl rapamycin and 31,42-d2-rapamycin and isomers thereof, and mixtures thereof. The deuterated rapamycin can also be glycosylated.
Patent NZ-542152-A (NZ)
Title: High swelling cold ramming paste for joining components of aluminium electrolysis cell
Inventor: MIRCHI AMIR A
IPC: C04B35/01
Filed: 2004-02-25
Abstract: A high swelling cold ramming paste for use in joining components of electrolytic cells for the electrolysis of alumina for the production of aluminium is disclosed, wherein the paste comprises a mixture of pitch and a carbonaceous aggregate containing anthracite, wherein the paste contains a light oil and said aggregate contains crushed anode butts or calcined coke with the crushed anode butts or calcined coke comprising up to 20% by weight of the total aggregate. The presence of the crushed anode butts or calcined coke increases the sodium swelling index of the paste by about four times higher than that of regular ramming pastes. This high swelling cold ramming paste may also contain an amount of a refractory hard material, such as titanium diboride TiB2.
Patent NZ-543499-A (NZ)
Title: Children's tooth and gum cleaning kit
Inventor: KLASSEN LAMBERTA A M
IPC: A46B5/04
Filed: 2004-04-08
Abstract: The present disclosure provides a cohesive progression of various sizes and shapes and styles of tooth and gum cleaning devices which are ideally suited to each stage of a child's physical and psychological development, and which maintain elements of familiarity to the child from stage to stage to make the progression less dramatic and less stressful to the child and to the caregiver. Several aspects of this disclosure have also been applied to tooth and gum cleaning devices for older children and adults and to powered toothbrush designs.